BIOLOGY

BIOLOGY

纳安生物

Company profile

Development history

Research layout

Dual anti-B830-ADC

  • Commodity name： Dual anti-B830-ADC
  • Field of treatment and diagnosis： Lung cancer, pancreatic cancer, esophageal cancer
  • Dosing type： Intravenous injection
  • Drug development stage： Preclinical
  • 产品描述

  • Data preparation.。。